en · de · es · fr · pt
cardarine-notes.peptides6579.com › Wiki › Mechanism And Detection — Explained

Mechanism And Detection — Explained

By Editorial Desk · published 2025-10-11 · last reviewed 2025-11-02 · Wiki

A practical reference on Investigational drug: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-11-02. Anything still debated is marked as such rather than presented as settled.

Mechanism and Detection

GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.

Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.

Cardarine as Investigational PPARδ Agonist

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Cardarine at a glance

PropertyValueNotes
Molecular targetPPAR delta (NR1C2)Ligand-activated nuclear receptor.
Primary tissues studiedSkeletal muscle, liver, adiposeEffects on fatty acid oxidation and energy use.
Typical detection matrixUrineUsed in anti-doping analysis.
Common analytical methodLC-MS/MSDetects parent compound and metabolites.
Sport regulatory classProhibited at all timesListed as a metabolic modulator by WADA.

Background and Research Context

Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.

PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.

Related pages on this site

Background and Regulatory History

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Notes from published material

==== In children ==== The NICE Guideline recommends that SSRIs should not be used to treat depression in children and young people, except for fluoxetine, which may be considered for moderate to severe depression when psychological therapies alone are insufficient. In the United States, they are approved for use in pediatric patients; however, individuals under 25 years of age should be closely monitored for an increased risk of suicidality, as indicated by the FDA black box warning. SSRIs have the best outcomes when combined with cognitive-behavioral therapy. Their benefits are modest and tolerability varies. The benefits may be clinically unimportant and there are uncertain effects on suicide risk.

Duterte introduced reforms to eliminate red tape in the government, and ordered government agencies to remove all processes which are "redundant or burdensome" to the public. Three weeks after assuming office, he issued his second executive order establishing Freedom of Information, allowing citizens to obtain documents and records from public offices under the executive branch to promote transparency in the government. In May 2018, Duterte signed the Ease of Doing Business Act which aims to create a better business environment by reducing processing time, cutting bureaucratic red tape, and eliminating corrupt practices in all government agencies. In December 2020, he enacted a law authorizing the president to expedite the processing and issuance of national and local permits, licenses, and certifications, by suspending its requirements, in times of national emergency. Duterte institutionalized the 8888 Citizens' Complaint Hotline in October 2016, allowing the public to report complaints on poor government front-line services and corrupt practices in all government agencies.

Deprotonation of the ring-OH group converts kojic acid to kojate. Kojate chelates to iron(III), forming a red complex Fe(HOCH2C5OH2O2)3. This kind of reaction may be the basis of the biological function of kojic acid, that is, to solubilize ferric iron. Being a multifunctional molecule, kojic acid has diverse organic chemistry. The hydroxymethyl group gives the chloromethyl derivative upon treatment with thionyl chloride. Zinc-reduction of the chloromethyl compound gives allomaltol.

Sources: en.wikipedia.org

Further detail

=== Legality === While butane-1,4-diol is not currently scheduled federally in the United States, a number of states have classified 1,4-butanediol as a controlled substance. Individuals have been prosecuted for possession of 1,4-butanediol under the Federal Analog Act as substantially similar to GHB. A federal case in New York in 2002 ruled that 1,4-butanediol could not be considered an analog of GHB under federal law, but that decision was later overturned by the Second Circuit. A jury in Federal District Court in Chicago found that 1,4-butanediol was not an analog of GHB under federal law, which was not disputed on the case's appeal to the Seventh Circuit Court of Appeals; however, this finding did not affect the outcome of the case. In the United Kingdom, 1,4-butanediol was scheduled in December 2009 (along with another GHB precursor, gamma-butyrolactone) as a Class C controlled substance. In Germany, the drug is not explicitly illegal, but might also be treated as illegal if used as a drug. It is controlled as a Schedule VI precursor in Canada.

To distribute the compressive forces exerted on the heel during gait, and especially the stance phase when the heel contacts the ground, the sole of the foot is covered by a layer of subcutaneous connective tissue up to 2 cm thick (under the heel). This tissue has a system of pressure chambers that both acts as a shock absorber and stabilises the sole. Each of these chambers contains fibrofatty tissue covered by a layer of tough connective tissue made of collagen fibers. These septa ("walls") are firmly attached both to the plantar aponeurosis above and the sole's skin below. The sole of the foot is one of the most highly vascularized regions of the body surface, and the dense system of blood vessels further stabilize the septa.

== History == Vertex Pharmaceuticals announced in January 2024 that suzetrigine had successfully met several endpoints in its phase III clinical trials. The company announced in July 2024 that the US Food and Drug Administration (FDA) had accepted a New Drug Application for suzetrigine. Due to its novel mechanism, the FDA granted priority review, fast track, and breakthrough therapy designations to the application for suzetrigine. In January 2025, the FDA granted approval of Journavx to Vertex Pharmaceuticals, making it the first non-opioid pain medication to be approved by the FDA in two decades. As of November 2025, phase IV post-marketing clinical trials are underway to assess the effectiveness and safety of suzetrigine as a part of multimodal therapy for the treatment of acute post-operative pain. The manufacturer engaged in lobbying activity promoting non-opioid pain treatment and supporting the NO PAIN Act (Non-Opioids Prevent Addiction In the Nation Act).

Sources: en.wikipedia.org

Background from the literature

A dihedral angle is the angle between two intersecting planes or half-planes. It is a plane angle formed on a third plane, perpendicular to the line of intersection between the two planes or the common edge between the two half-planes. In higher dimensions, a dihedral angle represents the angle between two hyperplanes. In chemistry, it is the clockwise angle between half-planes through two sets of three atoms, having two atoms in common.

Until the late 18th century, the Crimean Khanate (a Muslim Tatar state) maintained a massive slave trade with the Ottoman Empire and the Middle East. The slaves were captured in southern Russia, Poland-Lithuania, Moldavia, Wallachia, and Circassia by Tatar horsemen and sold in the Crimean port of Kaffa. About 2 million mostly Christian slaves were exported over the 16th and 17th centuries until the Crimean Khanate was destroyed by the Russian Empire in 1783. In Kievan Rus and Muscovy, slaves were usually classified as kholops. According to David P. Forsythe, "In 1649 up to three-quarters of Muscovy's peasants, or 13 to 14 million people, were serfs whose material lives were barely distinguishable from slaves. Perhaps another 1.5 million were formally enslaved, with Russian slaves serving Russian masters." Slavery remained a major institution in Russia until 1723, when Peter the Great converted the household slaves into house serfs. Russian agricultural slaves were formally converted into serfs earlier in 1679. Slavery in Poland was forbidden in the 15th century; in Lithuania, slavery was formally abolished in 1588; they were replaced by the second serfdom. In Scandinavia, thralldom was abolished in the mid-14th century. During the Age of Enlightenment, individuals, whether religious or not, held diverse and inconsistent beliefs about race and slavery and despite discussions on individual rights and freedoms; slavery was not abolished, but expanded significantly. The secular enlightenment allowed for scientific racism to emerge as a basis for slavery.

== The route == Though the route changes to accommodate various ports of call, the race typically departs Europe in October, and in recent editions has had either 9 or 10 legs, with in-port races at many of the stopover cities. The 2008–09 race started in Alicante, Spain, on October 11, 2008. The route for the 2008–2009 race was altered from previous years to include stopovers in India and Asia for the first time. The 2008–09 route covered nearly 39,000 nmi (72,000 km), took over nine months to complete, and reached a cumulative TV audience of 2 billion people worldwide. During the nine months of the 2011–12 Volvo Ocean Race, which started in Alicante, Spain, in October 2011 and concluded in Galway, Ireland, in July 2012, the teams were scheduled to sail over 39,000 nmi (72,000 km) of the world's most treacherous seas via Cape Town, Abu Dhabi, Sanya, Auckland, around Cape Horn to Itajaí, Miami, Lisbon, and Lorient. As in the previous editions, the 2014–15 Volvo Ocean Race started in Alicante, Spain, on October 11. Destination was Gothenburg, Sweden, scheduled for June 2015, with stopovers in the ports of Cape Town, Abu Dhabi, Sanya, Auckland, Itajaí, Newport, Lisbon, Lorient, and with a Pitstop at The Hague through the last leg.

Sources: en.wikipedia.org

Frequently asked questions

How does cardarine work in the body?

It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.

Did human trials show benefits?

Early-stage trials examined lipid and glucose markers, but the development program was discontinued. Published human results are limited and do not support approved use for any indication. Claims of performance or health benefits remain unproven.

Can anti-doping tests detect cardarine?

Yes. Laboratories use LC-MS/MS to detect GW501516 and its metabolites in urine. Detection depends on timing and sensitivity, but the substance is banned at all times.

What is cardarine?

Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.

Network